Cancer Drug Prices Slashed by Up to 70%: India's NPPA Caps Trade Margins at 30% on 137 Anti-Cancer Formulations From November 9
India's National Pharmaceutical Pricing Authority (NPPA) has capped trade margins at 30% on 137 non-scheduled anti-cancer drug formulations, effective November 9, 2026, with retail prices expected to fall by up to 70%. This article covers the key changes, which medicines are covered, how the move compares with the 2019 initiative, and how patients can check revised prices and protect their rights.